Crestor Star Continues To Rise, And Trajectory Looks Good
This article was originally published in The Pink Sheet Daily
Executive Summary
2009 should be a big year for the Crestor franchise, with filings based on the JUPITER trial and a fixed-dose combination with Abbott’s Trilipix.